Empery Asset Management, LP
13F Reported Value
ⓘ$86.5M
Holdings
32
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Empery Asset Management, LP disclosed 32 positions worth $86.5M in its Form 13F-HR for Q2 2026, led by $XFOR (X4 Pharmaceuticals, Inc) at 37.4% of the equity portfolio, followed by $EMPD and $NGEN. During the quarter the fund opened 11 new positions and exited 11 — including a new stake in $NGEN. The portfolio is most concentrated in Healthcare (75.8% of disclosed assets). All figures are sourced directly from Empery Asset Management, LP’s Form 13F-HR filing with the SEC under CIK 1469336.
Sector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 28.0#2,572
Quality
$32.4M6,930,591 sh - 7.5#2,944
Quality
$10.4M2,930,345 sh - —
Quality
$8.2M4,000,000 sh - 10.6
Quality
$6.1M776,093 sh - —
Quality
$5.6M916,532 sh - —
Quality
$4.5M2,401,476 sh - —
Quality
$3.5M842,669 sh - 42.8
Quality
$3.3M1,714,043 sh - —
Quality
$2.9M3,863,115 sh ONE AND ONE GREEN TECHNOLOGI - USD CL A ORD SHS
—Quality
$1.5M761,706 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 X4 Pharmaceuticals, Inc$XFOR | 28.0#2,572 | $32.4M | 6,930,591 |
 Empery Digital Inc.$EMPD | 7.5#2,944 | $10.4M | 2,930,345 |
 NERVGEN PHARMA CORP.$NGEN | — | $8.2M | 4,000,000 |
 PRECISION BIOSCIENCES INC$DTIL | 10.6 | $6.1M | 776,093 |
 Clene Inc.$CLNN | — | $5.6M | 916,532 |
 Annovis Bio, Inc.$ANVS | — | $4.5M | 2,401,476 |
 Lantern Pharma Inc.$LTRN | — | $3.5M | 842,669 |
 AMC ENTERTAINMENT HOLDINGS, INC.$AMC | 42.8 | $3.3M | 1,714,043 |
 Tenaya Therapeutics, Inc.$TNYA | — | $2.9M | 3,863,115 |
| ONE AND ONE GREEN TECHNOLOGI - USD CL A ORD SHS | — | $1.5M | 761,706 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Empery Asset Management, LP's 32 positions.
Showing top 10 of 32 holdings.
Sector Allocation
Healthcare
$65.5M
Industrials
$10.5M
Communication Services
$4.4M
Other
$1.8M
Materials
$1.7M
Technology
$1.3M
Energy
$850,000
Financials
$326,912
Full Holdings — Empery Asset Management, LP (Q2 2026)
All 32 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $XFOR | X4 Pharmaceuticals, Inc | $32.4M | 37.4% | -23% | 28 |
| 2 | $EMPD | Empery Digital Inc. | $10.4M | 12.1% | +0% | 7.5 |
| 3 | $NGEN | NERVGEN PHARMA CORP. | $8.2M | 9.5% | NEW | — |
| 4 | $DTIL | PRECISION BIOSCIENCES INC | $6.1M | 7.0% | -61% | 10.6 |
| 5 | $CLNN | Clene Inc. | $5.6M | 6.5% | NEW | — |
| 6 | $ANVS | Annovis Bio, Inc. | $4.5M | 5.2% | NEW | — |
| 7 | $LTRN | Lantern Pharma Inc. | $3.5M | 4.1% | NEW | — |
| 8 | $AMC | AMC ENTERTAINMENT HOLDINGS, INC. | $3.3M | 3.8% | NEW | 42.8 |
| 9 | $TNYA | Tenaya Therapeutics, Inc. | $2.9M | 3.3% | -10% | — |
| 10 | — | ONE AND ONE GREEN TECHNOLOGI - USD CL A ORD SHS | $1.5M | 1.8% | NEW | — |
| 11 |  $CYN | Cyngn Inc. | $1.3M | 1.5% | -3% | — |
| 12 |  $VENU | Venu Holding Corp | $1.2M | 1.4% | -49% | 23 |
| 13 |  $GLND | Greenland Energy Co | $850,000 | 1.0% | NEW | — |
| 14 |  $URG | UR-ENERGY INC | $843,385 | 1.0% | +0% | 28 |
| 15 |  $MSLE | Satellos Bioscience Inc. | $832,703 | 1.0% | -53% | — |
| 16 |  $JAGU | Jaguar Uranium Corp. | $814,125 | 0.9% | +0% | — |
| 17 |  $CLRB | Cellectar Biosciences, Inc. | $527,102 | 0.6% | NEW | — |
| 18 |  $SCYX | SCYNEXIS INC | $514,656 | 0.6% | -93% | — |
| 19 |  $RNTX | Rein Therapeutics, Inc. | $385,667 | 0.5% | NEW | — |
| 20 |  $BTCT | BTC Digital Ltd. | $288,912 | 0.3% | NEW | — |
| 21 | — | BRIACELL THERAPEUTICS CORP - *W EXP 01/15/203 | $267,000 | 0.3% | +0% | — |
| 22 |  $MTEK | Maris Tech Ltd. | $58,032 | 0.1% | +0% | — |
| 23 |  $PRZO | ParaZero Technologies Ltd. | $55,338 | 0.1% | -60% | — |
| 24 |  $DUKR | DUKE Robotics Corp. | $45,150 | 0.1% | NEW | 7.1 |
| 25 |  $NTRB | NutriBand Inc. | $40,218 | 0.1% | +0% | 9.9 |
| 26 |  $RTAC | Renatus Tactical Acquisition Corp I | $38,000 | 0.0% | +0% | — |
| 27 |  $MDAI | Spectral AI, Inc. | $18,501 | 0.0% | +0% | 28 |
| 28 |  $NEXR | Nexera Technologies Ltd | $10,421 | 0.0% | +0% | — |
| 29 |  $BNC | CEA Industries Inc. | $9,250 | 0.0% | +0% | 55.1 |
| 30 |  $FGI | FGI Industries Ltd. | $7,973 | 0.0% | +0% | — |
| 31 |  $NRSN | NeuroSense Therapeutics Ltd. | $6,325 | 0.0% | +0% | — |
| 32 |  $NXGL | NEXGEL, INC. | $3,474 | 0.0% | +0% | — |
New Positions (11)
$NGEN NERVGEN PHARMA CORP.$8.2M$CLNN Clene Inc.$5.6M$ANVS Annovis Bio, Inc.$4.5M$LTRN Lantern Pharma Inc.$3.5M$AMC AMC ENTERTAINMENT HOLDINGS, INC.$3.3M$GLND Greenland Energy Co$850,000$CLRB Cellectar Biosciences, Inc.$527,102$RNTX Rein Therapeutics, Inc.$385,667$BTCT BTC Digital Ltd.$288,912$DUKR DUKE Robotics Corp.$45,150
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Empery Asset Management, LP including:
Track Empery Asset Management, LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Empery Asset Management, LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Empery Asset Management, LP
13F Pro is an AI hedge fund tracker and stock research platform. For Empery Asset Management, LP (SEC CIK: 1469336), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Empery Asset Management, LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.